RIHAWI, KARIM
RIHAWI, KARIM
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary
2024 Cavazzoni A.; Salamon I.; Fumarola C.; Gallerani G.; Laprovitera N.; Gelsomino F.; Riefolo M.; Rihawi K.; Porcellini E.; Rossi T.; Mazzeschi M.; Naddeo M.; Serravalle S.; Broseghini E.; Agostinis F.; Deas O.; Roncarati R.; Durante G.; Pace I.; Lauriola M.; Garajova I.; Calin G.A.; Bonafe M.; D'Errico A.; Petronini P.G.; Cairo S.; Ardizzoni A.; Sales G.; Ferracin M.
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale
2022 Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Follador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer
2022 Giuseppe Filitto; Francesca Coppola; Nico Curti; Enrico Giampieri; Daniele Dall'Olio; Alessandra Merlotti; Arrigo Cattabriga; Maria Adriana Cocozza; Makoto Taninokuchi Tomassoni; Daniel Remondini; Luisa Pierotti; Lidia Strigari; Dajana Cuicchi; Alessandra Guido; Karim Rihawi; Antonietta D???Errico; Francesca Di Fabio; Gilberto Poggioli; Alessio Giuseppe Morganti; Luigi Ricciardiello; Rita Golfieri; Gastone Castellani
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization
2022 Donatella Romaniello, Valerio Gelfo, Federica Pagano, Enea Ferlizza, Michela Sgarzi, Martina Mazzeschi, Alessandra Morselli, Carmen Miano, Moshit Lindzen, Gabriele D’Uva, Francesco Fazi, Luca Tamagnone, Karim Rihawi, Andrea Ardizzoni, Yosef Yarden, Mattia Lauriola
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
2022 Mazzeschi, Martina; Sgarzi, Michela; Romaniello, Donatella; Gelfo, Valerio; Cavallo, Carola; Ambrosi, Francesca; Morselli, Alessandra; Miano, Carmen; Laprovitera, Noemi; Girone, Cinzia; Ferracin, Manuela; Santi, Spartaco; Rihawi, Karim; Ardizzoni, Andrea; Fiorentino, Michelangelo; D'Uva, Gabriele; Győrffy, Balázs; Palmer, Ruth; Lauriola, Mattia
Expected and non-expected immune-related adverse events detectable by CT
2021 Ciccarese F.; Piccinino A.; Brocchi S.; Balacchi C.; Dall'Olio F.G.; Massari F.; Rihawi K.; Paccapelo A.; Ardizzoni A.; Golfieri R.
Novel HER2-directed treatments in advanced gastric carcinoma: Another paradigm shift?
2021 Ricci A.D.; Rizzo A.; Llimpe F.L.R.; Fabio F.D.; De Biase D.; Rihawi K.
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series
2021 Brocchi S.; Parmeggiani A.; Gaudiano C.; Balacchi C.; Renzulli M.; Brandi N.; Dall'olio F.G.; Rihawi K.; Ardizzoni A.; Golfieri R.
Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications
2021 Rihawi K.; Ricci A.D.; Rizzo A.; Brocchi S.; Marasco G.; Pastore L.V.; Llimpe F.L.R.; Golfieri R.; Renzulli M.
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study
2020 Ricci C.; Capizzi E.; Giunchi F.; Casolari L.; Gelsomino F.; Rihawi K.; Natali F.; Livi V.; Trisolini R.; Fiorentino M.; Ardizzoni A.
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies
2020 Valerio Gelfo; Donatella Romaniello; Martina Mazzeschi; Michela Sgarzi; Giada Grilli; Alessandra Morselli; Beatrice Manzan; Karim Rihawi; Mattia Lauriola
BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience
2019 Rihawi K ; Giannarelli D ; Galetta D ; Delmonte A ; Giavarra M ; Turci D ; Garassino M ; Tiseo M ; Barbieri ; Panni S ; Ardizzoni A;
Emerging therapies in malignant pleural mesothelioma
2019 Cinausero M.; Rihawi K.; Cortiula F.; Follador A.; Fasola G.; Ardizzoni A.
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report
2019 Rihawi, Karim; Alfieri, Roberta; Fiorentino, Michelangelo; Fontana, Francesca; Capizzi, Elisa; Cavazzoni, Andrea; Terracciano, Mario; La Monica, Silvia; Ferrarini, Alberto; Buson, Genny; Petronini, Pier Giorgio; Ardizzoni, Andrea
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
2018 Ferrarini A, Forcato C, Buson G, Tononi P, Del Monaco V, Terracciano M, Bolognesi C, Fontana F, Medoro G, Neves R, Möhlendick B, Rihawi K, Ardizzoni A, Sumanasuriya S, Flohr P, Lambros M, de Bono J, Stoecklein NH, Manaresi N
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding
2018 Dall'Olio, Filippo Gustavo; Sperandi, Francesca; Rihawi, Karim; Gargiulo, Mauro; Melotti, Barbara; Brocchi, Stefano; Gelsomino, Francesco*; Ardizzoni, Andrea
Chemotherapy treatment in malignant pleural mesothelioma: A difficult history
2018 Cinausero, Marika; Rihawi, Karim*; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins
2018 Rihawi K, Cinausero M, Fiorentino M, Salvagni S, Brocchi S, Ardizzoni A
Immune checkpoint inhibition in small cell lung cancer: A key to reach an unmet need?
2017 Gelsomino F.; Leonetti A.; Rihawi K.; Sperandi F.; Casolari L.; Melotti B.; Fiorentino M.; Ardizzoni A.
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: A review of current evidence
2017 Rihawi, Karim; Gelsomino, Francesco*; Sperandi, Francesca; Melotti, Barbara; Fiorentino, Michelangelo; Casolari, Laura; Ardizzoni, Andrea
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary | Cavazzoni A.; Salamon I.; Fumarola C.; Gallerani G.; Laprovitera N.; Gelsomino F.; Riefolo M.; Ri...hawi K.; Porcellini E.; Rossi T.; Mazzeschi M.; Naddeo M.; Serravalle S.; Broseghini E.; Agostinis F.; Deas O.; Roncarati R.; Durante G.; Pace I.; Lauriola M.; Garajova I.; Calin G.A.; Bonafe M.; D'Errico A.; Petronini P.G.; Cairo S.; Ardizzoni A.; Sales G.; Ferracin M. | 2024-01-01 | MOLECULAR THERAPY | - | 1.01 Articolo in rivista | - |
| A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale | Andrini, Elisa; Lamberti, Giuseppe; Mazzoni, Francesca; Riccardi, Ferdinando; Bonetti, Andrea; Fo...llador, Alessandro; Artioli, Fabrizio; Genova, Carlo; Barbieri, Fausto; Frassoldati, Antonio; Brighenti, Matteo; Colantonio, Ida; Pasello, Giulia; Ficorella, Corrado; Cinieri, Saverio; Tiseo, Marcello; Gelsomino, Francesco; Tognetto, Michele; Rihawi, Karim; Ardizzoni, Andrea | 2022-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer | Giuseppe Filitto; Francesca Coppola; Nico Curti; Enrico Giampieri; Daniele Dall'Olio; Alessandra ...Merlotti; Arrigo Cattabriga; Maria Adriana Cocozza; Makoto Taninokuchi Tomassoni; Daniel Remondini; Luisa Pierotti; Lidia Strigari; Dajana Cuicchi; Alessandra Guido; Karim Rihawi; Antonietta D???Errico; Francesca Di Fabio; Gilberto Poggioli; Alessio Giuseppe Morganti; Luigi Ricciardiello; Rita Golfieri; Gastone Castellani | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-02231-v3.pdf |
| IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization | Donatella Romaniello, Valerio Gelfo, Federica Pagano, Enea Ferlizza, Michela Sgarzi, Martina Mazz...eschi, Alessandra Morselli, Carmen Miano, Moshit Lindzen, Gabriele D’Uva, Francesco Fazi, Luca Tamagnone, Karim Rihawi, Andrea Ardizzoni, Yosef Yarden, Mattia Lauriola | 2022-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer | Mazzeschi, Martina; Sgarzi, Michela; Romaniello, Donatella; Gelfo, Valerio; Cavallo, Carola; Ambr...osi, Francesca; Morselli, Alessandra; Miano, Carmen; Laprovitera, Noemi; Girone, Cinzia; Ferracin, Manuela; Santi, Spartaco; Rihawi, Karim; Ardizzoni, Andrea; Fiorentino, Michelangelo; D'Uva, Gabriele; Győrffy, Balázs; Palmer, Ruth; Lauriola, Mattia | 2022-01-01 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | s13046-022-02309-1.pdf; 19451499.zip |
| Expected and non-expected immune-related adverse events detectable by CT | Ciccarese F.; Piccinino A.; Brocchi S.; Balacchi C.; Dall'Olio F.G.; Massari F.; Rihawi K.; Pacca...pelo A.; Ardizzoni A.; Golfieri R. | 2021-01-01 | EUROPEAN JOURNAL OF RADIOLOGY | - | 1.01 Articolo in rivista | - |
| Novel HER2-directed treatments in advanced gastric carcinoma: Another paradigm shift? | Ricci A.D.; Rizzo A.; Llimpe F.L.R.; Fabio F.D.; De Biase D.; Rihawi K. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-01664.pdf |
| Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series | Brocchi S.; Parmeggiani A.; Gaudiano C.; Balacchi C.; Renzulli M.; Brandi N.; Dall'olio F.G.; Rih...awi K.; Ardizzoni A.; Golfieri R. | 2021-01-01 | ACTA GASTRO-ENTEROLOGICA BELGICA | - | 1.01 Articolo in rivista | - |
| Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications | Rihawi K.; Ricci A.D.; Rizzo A.; Brocchi S.; Marasco G.; Pastore L.V.; Llimpe F.L.R.; Golfieri R....; Renzulli M. | 2021-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-22-03805.pdf |
| Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study | Ricci C.; Capizzi E.; Giunchi F.; Casolari L.; Gelsomino F.; Rihawi K.; Natali F.; Livi V.; Triso...lini R.; Fiorentino M.; Ardizzoni A. | 2020-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | 1758835920954802.pdf |
| Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies | Valerio Gelfo; Donatella Romaniello; Martina Mazzeschi; Michela Sgarzi; Giada Grilli; Alessandra ...Morselli; Beatrice Manzan; Karim Rihawi; Mattia Lauriola | 2020-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-21-06009.pdf |
| BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience | Rihawi K ; Giannarelli D ; Galetta D ; Delmonte A ; Giavarra M ; Turci D ; Garassino M ; Tiseo M... ; Barbieri ; Panni S ; Ardizzoni A; | 2019-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Emerging therapies in malignant pleural mesothelioma | Cinausero M.; Rihawi K.; Cortiula F.; Follador A.; Fasola G.; Ardizzoni A. | 2019-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | cinausero2019.pdf |
| MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report | Rihawi, Karim; Alfieri, Roberta; Fiorentino, Michelangelo; Fontana, Francesca; Capizzi, Elisa; Ca...vazzoni, Andrea; Terracciano, Mario; La Monica, Silvia; Ferrarini, Alberto; Buson, Genny; Petronini, Pier Giorgio; Ardizzoni, Andrea | 2019-01-01 | TRANSLATIONAL ONCOLOGY | - | 1.01 Articolo in rivista | 1-s2.0-S193652331830384X-main.pdf |
| A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products. | Ferrarini A, Forcato C, Buson G, Tononi P, Del Monaco V, Terracciano M, Bolognesi C, Fontana F, M...edoro G, Neves R, Möhlendick B, Rihawi K, Ardizzoni A, Sumanasuriya S, Flohr P, Lambros M, de Bono J, Stoecklein NH, Manaresi N | 2018-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | journal.pone.0193689.pdf |
| Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding | Dall'Olio, Filippo Gustavo; Sperandi, Francesca; Rihawi, Karim; Gargiulo, Mauro; Melotti, Barbara...; Brocchi, Stefano; Gelsomino, Francesco*; Ardizzoni, Andrea | 2018-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Chemotherapy treatment in malignant pleural mesothelioma: A difficult history | Cinausero, Marika; Rihawi, Karim*; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea | 2018-01-01 | JOURNAL OF THORACIC DISEASE | - | 1.04 Replica / breve intervento (e simili) | - |
| Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins | Rihawi K, Cinausero M, Fiorentino M, Salvagni S, Brocchi S, Ardizzoni A | 2018-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Immune checkpoint inhibition in small cell lung cancer: A key to reach an unmet need? | Gelsomino F.; Leonetti A.; Rihawi K.; Sperandi F.; Casolari L.; Melotti B.; Fiorentino M.; Ardizz...oni A. | 2017-01-01 | TRANSLATIONAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Pembrolizumab in the treatment of metastatic non-small cell lung cancer: A review of current evidence | Rihawi, Karim; Gelsomino, Francesco*; Sperandi, Francesca; Melotti, Barbara; Fiorentino, Michelan...gelo; Casolari, Laura; Ardizzoni, Andrea | 2017-01-01 | THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | - | 1.01 Articolo in rivista | 10.1177_1753465817725486.pdf |